Dave Weiner

Stock Analyst at Piper Sandler

(2.32)

# 2,401

Out of 4,820 analysts

7

Total ratings

50%

Success rate

14.34%

Average return

Main Sectors:

Healthcare Consumer Discretionary

Top Industries:

Diagnostics & Research Apparel Retail

Stocks Rated by Dave Weiner

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MYGN Myriad Genetics	Upgrades: Overweight	$12 → $13	$7.42	+68.46%	2	Mar 12, 2025
	LULU lululemon athletica inc.	Upgrades: Buy	n/a	$267.90	-	5	Dec 14, 2017

Myriad Genetics

Mar 12, 2025

Upgrades: Overweight

Price Target: $12 → $13

Current: $7.42

Upside: +68.46%

lululemon athletica inc.

Dec 14, 2017

Upgrades: Buy

Price Target: n/a

Current: $267.90

Upside: -